Does rituximab treat recurrent focal segmental glomerulosclerosis post-renal transplantation?
- PMID: 16937130
- DOI: 10.1007/s00467-006-0260-x
Does rituximab treat recurrent focal segmental glomerulosclerosis post-renal transplantation?
Comment on
-
Rituximab treatment for posttransplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephrotic syndrome.Pediatr Nephrol. 2005 Nov;20(11):1660-3. doi: 10.1007/s00467-005-2013-7. Epub 2005 Aug 16. Pediatr Nephrol. 2005. PMID: 16133051
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
